A long-awaited oral multiple sclerosis drug from Merck KGaA was among a raft of medicines given the green light by Europe's regulator on Friday. Europe’s CHMP top scientific committee gave a positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback